title: Cytoimmunological monitoring after homograft valve replacement.
abstract: Examination results concerning immunological reactions in cryopreserved allograft valves during the early postoperative course are so far not available. Cytoimmunological monitoring (CIM) is a well established method to prove rejection reaction after allograft transplantation and was used in this study. Allograft valves were harvested from patients who underwent heart transplantation, and did not require sterilizing in antibiotic solutions. The valves were dissected, conserved and subsequently frozen to -40 degrees C and stored in a freezing system at -196 degrees C. During the first 3 weeks following allograft implantation, CIM was performed daily. An activation index (AI) was determined from the cytological evaluation of the mononuclear concentrate in the peripheral blood. An increase of the AI > 1 was defined as an immunological reaction. As control we performed 98 CIM examinations in eight patients who underwent bioprosthetic valve replacement in the aortic position. Echocardiography (TTE and TEE) was used postoperatively as function control. Out of 16 patients who underwent cryopreserved aortic valve implantation in the aortic position, 336 CIM-results were obtained. An immunological reaction could be detected in all patients, starting on the 5th day on average. Comparing ABO-compatible (group I, n = 9) with ABO-incompatible (group II, n = 7) allografts, the AI-maximum in group I was 1.4 with a mean duration of 1.5 days. Group II was characterized by more intensive immunoreactions (mean = 2.3) which proved to be even more prolonged (mean = 3.3 days, P < 0.05). Nevertheless it became apparent that all observed immunological events were completely reversible without the need for immunosuppressive drugs.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Cardiovascular Surgery, Klinikum Bogenhausen, Munich, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Schütz
authors.forename: T
authors.initials: T
authors.lastname: Fischlein
authors.forename: M
authors.initials: M
authors.lastname: Breuer
authors.forename: M
authors.initials: M
authors.lastname: Haushofer
authors.forename: A
authors.initials: A
authors.lastname: Uhlig
authors.forename: C
authors.initials: C
authors.lastname: Detter
authors.forename: B M
authors.initials: BM
authors.lastname: Kemkes
authors.forename: C
authors.initials: C
authors.lastname: Hammer
authors.forename: B
authors.initials: B
authors.lastname: Reichart
mesh_terms: D000017:ABO Blood-Group System; D001021:Aortic Valve / Q000000981:diagnostic imaging / Q000276:immunology / Q000637:transplantation*; D001705:Bioprosthesis; D015925:Cryopreservation; D017548:Echocardiography, Transesophageal; D006350:Heart Valve Prosthesis / Q000379:methods*; D006650:Histocompatibility Testing; D006801:Humans; D011184:Postoperative Period; D014181:Transplantation Immunology
chemical_list: D000017:ABO Blood-Group System